title: Granulocytic sarcoma of the right humerus in a non-leukaemia patient.
abstract: Granulocytic sarcoma (GS), an uncommon solid extramedullary tumour, should be considered even in the absence of leukaemia, as delay in diagnosis and treatment worsens the prognosis. We present a GS (single humeral bone lesion) in a non-leukaemia patient, treated with intensive AML (Acute Myeloid Leukaemia) chemotherapy and sequential radiotherapy, in complete response 26 months after diagnosis, confirmed by histopathology and without leukaemia progression.
authors.affiliation: Radiation Oncology Department, Hospital Central de la Defensa Gómez-Ulla, Madrid, Spain. auroraroper@terra.es
authors.forename: Aurora
authors.initials: A
authors.lastname: Rodríguez Pérez
authors.forename: Maria Concepcion
authors.initials: MC
authors.lastname: López Carrizosa
authors.forename: Lucia
authors.initials: L
authors.lastname: Villalón Blanco
authors.forename: Pilar Maria
authors.initials: PM
authors.lastname: Samper Ots
authors.forename: Eduardo
authors.initials: E
authors.lastname: Ortiz Cruz
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019643:Arthroplasty, Replacement; D001859:Bone Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000601:surgery; D006801:Humans; D006811:Humerus / Q000473:pathology* / Q000601:surgery; D015255:Idarubicin / Q000008:administration & dosage; D010014:Osteolysis / Q000209:etiology; D012074:Remission Induction; D023981:Sarcoma, Myeloid / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D012784:Shoulder Fractures / Q000209:etiology / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D015255:Idarubicin